1. Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China. Y. CAO, K. CAI, L. XIONG. Acta virologica 64: 245– 250, 2020
2. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou and Lanying Du. Cellular & Molecular Immunology (2020) 17:613–620; https://doi.org/10.1038/s41423-020-0400-4
3. Новая коронавирусная инфекция (COVID-19): клинико-эпидемиологические аспекты. В.В. Никифоров, Т.Г. Суранова, Т.Я. Чернобровкина, Я.Д. Янковская, С.В. Бурова. Архивъвнутреннеймедицины № 2 2020 [Novel coronavirus infection (COVID-19): clinical and epidemiological aspects. V.V. Nikiforov, T.G. Suranova, T.Ja. Chernobrovkina, Ja.D. Jankovskaja, S.V. Burova. Arhiv vnutrennej mediciny № 2 2020 (in Russ.)].
4. Gastroenterology. 2020 May; 158(6): 1518–1519. Published online 2020 Mar. COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission. Jinyang Gu, Bing Han, and Jian Wang
5. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Jaewon J. Lee, Scott Kopetz, Eduardo Vilar, John Paul Shen, Ken Chen and Anirban Maitra. Genes 2020 june; 11 (6): 645
6. Коронавирусная инфекция COVID-2019. Б. К. Романов. Безопасность и риск фармакотерапии 2020. Т. 8, № 1. [Coronavirus infection COVID-2019. B. K. Romanov. Bezopasnost' i risk farmakoterapii 2020. T. 8, № 1 (in Russ.)].
7. Gastroenterology Practis in COVID-19 Pandemic. Lu Xia, Kaichun Wu. E-WGO
8. COVID-19 и поражение печени. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. Архивъ внутренней медицины. 2020;10(3):188-197 [COVID-19 andliverdamage. Il'chenkoL.Ju., NikitinI.G., FedorovI.G. Arhivvnutrennejmediciny. 2020;10(3):188-197 (inRuss.)].
9. Инфекция COVID-19 и органы пищеварения. Д.С. Бордин, М.А. Кирюкова, М.И. Шенгелия,С.В. Колбасников. Эффективная фармакотерапия. 2020. Том 16. № 1 [COVID-19 infection and digestive organs. D.S. Bordin, M.A. Kirjukova, M.I. Shengelija,S.V. Kolbasnikov. Jeffektivnajafarmakoterapija. 2020. Tom 16. № 1 (inRuss.)].
10. JinX., LianJS, HuJH, GaoJ., ZhengL., ZhangYM, HaoSR, JiaHY, CaiH., ZhangXL. Epidemiological, clinical and virological characteristics of 74 cases of the disease infected with coronavirus 2019 (COVID-19) with gastrointestinal symptoms. Intestine, 2020; 69: 1002-1009
11. Mart M. Lamers, Joep Beumer, Jelte van der Vaart et al. SARS-CoV-2 productively infects human gut enterocyte. Science 03 Jul 2020
12. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. SONIA VILLAPOL, 2020
13. Don’t Overlook Digestive Symptoms in Patients With Novel Coronavirus Diseas (Covid-19). Shihua Luo, Xiaochun Zhang and Halido Xu. Clinical Gastroenterology and Hepatology 2020;18:1636–1637
14. D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol 2020;18:1663–7
15. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID- 19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroen- terol. 2020;115:766–73
16. Lin L., Jiang X., Zhang Z., Huang S., Zhang Z., Fang Z., al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020; 69(6):997–1001 DOI: 10.1136/gutjnl-2020-321013
17. Parasa S, Desai M, Thoguluva Chandrasekar V, et al. Prevalence of gastrointestinal symptoms and fecal viral shed- ding in patients with Coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2011335
18. Song Y., Liu P., Shi X.L., Chu J.L., Zhang J., Xia J., et al. SARS-CoV-2 induced diarrhea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143–44. DOI: 10.1136/gutjnl-2020-320891
19. First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine. March 5, 2020
20. COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests. Lijuan Chen, Jianghua Lou, Yan Bai and Meiyun Wang. Am J Gastroenterol 2020;115:790
21. Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020. https ://doi. org/10.1002/jmv.25742
22. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020. https ://doi.org/10.1053/j.gastr o.2020.02.055
23. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Tatsuo Hashimoto , Thomas Perlot. Nature 2012 Jul 25;487(7408):477-81)
24. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak. Published Online March 25, 2020 https://doi.org/10.1016/ S2468-1253(20)30085-6
25. Mazza S., Sorce A., Peyvandy F., Vecchi M., Cap- rioli F. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut. 2020;69(6):1148–49. DOI: 10.1136/gutjnl-2020-321183
26.https://www.crohnscolitisfoundation.org/coronavirus/ibd-medication
27. Rubin D.T., Abrey M.T., Rai V., Siegel C.A. Interna- tional Organization for the Study of Inflammatory Bowel Disease. Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting. Gastroenterology. 2020; S0016-5085(20)30465-0. DOI: 10.1053/j.gas- tro.2020.04.002
28.https://www.crohnscolitisfoundation.org/coronavirus/ibd-medication